Manuel Jesús Romero-Jiménez,María Elena Mansilla-Rodríguez
Manuel Jesús Romero-Jiménez
Purpose of review: Familial Hypercholesterolemia is associated with an increased risk of cardiovascular disease. The current international guidelines of the main scientific societies consider that all people with familial...
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders [0.03%]
与纤维细胞生长因子23相关的低磷血症相关疾病的新进展
Yuichi Takashi,Daiji Kawanami,Seiji Fukumoto
Yuichi Takashi
Purpose of review: Fibroblast growth factor 23 (FGF23) is a hormone to reduce blood phosphate concentration. Excessive actions of FGF23 induce FGF23-related hypophosphatemic disorders, such as X-linked hypophosphatemic ri...
Francesco Inchingolo,Angelo Michele Inchingolo,Fabio Piras et al.
Francesco Inchingolo et al.
Purpose of review: This review critically examines interconnected health domains like gut microbiome, bone health, interleukins, chronic periodontitis, and coronavirus disease 2019 (COVID-19), offering insights into funda...
Khushboo Gala,Wissam Ghusn,Barham K Abu Dayyeh
Khushboo Gala
Purpose of review: Metabolic and bariatric surgery (MBS) and endoscopic bariatric therapies (EBT) are being increasingly utilized for the management of obesity. They work through multiple mechanisms, including restriction...
So-Hyeon Hong,Kyung Mook Choi
So-Hyeon Hong
Purpose of review: Various gut hormones interact with the brain through delicate communication, thereby influencing appetite and subsequent changes in body weight. This review summarizes the effects of gut hormones on app...
Kevin Z Huang,H Christian Weber
Kevin Z Huang
Purpose of review: Potassium-competitive acid blockers (PCABs) represent a new class of compounds for the treatment of acid-related disorders. Recent FDA approval of the PCAB vonoprazan for erosive esophagitis has started...
Gerald F Watts,Dick C Chan
Gerald F Watts
Jasmine Chebli,Miriam Larouche,Daniel Gaudet
Jasmine Chebli
Purpose of review: The aim of this review is to present the clinical indications of apolipoprotein C-III (apoC3) inhibition in the therapeutic arsenal for the treatment of lipid disorders and associated risks and to compa...
Lynne L Levitsky
Lynne L Levitsky